O’Connell, Susan http://orcid.org/0000-0002-5887-2771
Dale, Megan
Morgan, Helen
Carter, Kimberley
Morris, Rhys
Carolan-Rees, Grace
Article History
Accepted: 27 May 2021
First Online: 28 July 2021
Declarations
: This article was not externally peer reviewed by PharmacoEconomics – Open. This article was reviewed by NICE.
: Cedar was funded by the NICE Medical Technologies Evaluation Programme for their work.
: Susan O’Connell, Megan Dale and Rhys Morris are employees of the NHS, and Grace Carolan-Rees was an employee of the NHS until September 2020, which has a financial interest in the guidance on which this project is based. Helen Morgan is a Cardiff University employee and has no conflicts of interest that are directly relevant to the content of this article. Kimberley Carter is a NICE employee and had no role in the production of the assessment report but contributed to the preparation of this manuscript. This summary of the MTG was produced following publication of the final guidance report.
: Not Applicable.
: SOC, MD, HM, RM, GCR and KC contributed to the preparation of this manuscript. GCR reviewed the full assessment report as well as this article. RM reviewed the article and can act as a guarantor for the overall content.